06:29 AM EDT, 05/06/2024 (MT Newswires) -- Integrated LifeSciences Holdings (IART) reported Q1 adjusted earnings Monday of $0.55 per diluted share, down from $0.74 a year earlier.

Analysts polled by Capital IQ expected $0.55.

Revenue for the quarter ended March 31 was $368.9 million, compared with $380.8 million a year earlier.

Analysts surveyed by Capital IQ expected $362 million.

For full-year 2024, the company decreased its adjusted EPS guidance outlook to now be between $3.01 and $3.11 from the prior outlook range of between $3.15 and $3.25. Analysts surveyed by Capital IQ expect $3.19.

The revenue outlook for the year is now projected to be $1.67 billion to $1.69 billion from the prior outlook of $1.6 billion to $1.62 billion. Analysts polled by Capital IQ expect $1.62 billion.

The company said it expects Q2 adjusted earnings of $0.60 to $0.65 per share. Analysts surveyed by Capital IQ expect $0.74.

Revenue for the quarter is expected to be $411 million to $416 million. Analysts polled by Capital IQ expect $395.8 million.